Healthpeak (DOC) analyst forecast and price target
Analyst forecast
Consensus of 22 analyst ratings
Based on 11 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Barclays | Maintained | Equal-Weight | $24.00 from $23.00 | Aug 31, 2026 |
| Baird | Maintained | Outperform | $24.00 from $21.00 | Aug 13, 2026 |
| Citigroup | Maintained | Neutral | $22.00 from $20.00 | Aug 11, 2026 |
| RBC Capital | Maintained | Outperform | $24.00 from $21.00 | Aug 10, 2026 |
| Cantor Fitzgerald | Maintained | Neutral | $23.00 from $20.00 | Aug 6, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $22.00 from $20.00 | Jul 15, 2026 |
| UBS | Maintained | Neutral | $21.50 from $19.00 | Jul 8, 2026 |
| Barclays | Initiated Coverage | Overweight → Equal-Weight | $23.00 | Jul 7, 2026 |
| Mizuho | Maintained | Outperform | $24.00 from $21.00 | Jul 6, 2026 |
| JP Morgan | Maintained | Neutral | $21.00 from $18.00 | Jun 24, 2026 |
| Raymond James | Maintained | Outperform → Market Perform | — | Jun 17, 2026 |
| BMO Capital | Maintained | Outperform | $24.00 from $20.00 | Jun 15, 2026 |
| Morgan Stanley | Downgraded | Overweight → Equal-Weight | $22.00 from $20.00 | Jun 11, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $20.00 from $18.00 | Jun 1, 2026 |
| Scotiabank | Maintained | Sector Perform | $21.00 from $19.00 | May 27, 2026 |
| Morgan Stanley | Maintained | Overweight | $20.00 from $18.00 | May 22, 2026 |
| RBC Capital | Maintained | Outperform | $21.00 from $20.00 | May 14, 2026 |
| Baird | Maintained | Outperform | $21.00 from $19.00 | May 13, 2026 |
| UBS | Maintained | Neutral | $19.00 from $17.00 | May 13, 2026 |
| Citigroup | Maintained | Neutral | $20.00 from $17.50 | May 12, 2026 |
Frequently asked questions
What is the price target for DOC stock?
The average 12-month analyst price target for Healthpeak (DOC) is $22.86, with a high estimate of $24.00 and a low of $21.00, across 11 analysts.
Is DOC a buy, sell, or hold?
Analysts covering Healthpeak currently average a Hold rating: 8 buy, 14 hold and 0 sell, from 22 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for DOC?
The average price target of $22.86 implies 10.19% upside from the last price of $20.75.
What is the latest analyst rating on DOC?
On Aug 31, 2026, Barclays maintained Healthpeak at Equal-Weight with a price target of $24.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.